Valeritas Holdings, Inc. (NASDAQ:VLRX) posted its quarterly earnings data on Friday. The company reported ($1.83) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.87) by $0.04, MarketWatch Earnings reports. The firm had revenue of $4.79 million during the quarter, compared to analyst estimates of $5.11 million.

Valeritas Holdings (NASDAQ VLRX) traded down 11.17% on Friday, reaching $5.01. 22,455 shares of the company’s stock were exchanged. Valeritas Holdings has a 12-month low of $4.51 and a 12-month high of $50.00. The company’s market cap is $34.28 million. The firm has a 50 day moving average of $5.92 and a 200-day moving average of $12.45.

In other Valeritas Holdings news, insider John Edward Timberlake purchased 5,000 shares of the stock in a transaction dated Wednesday, May 17th. The shares were acquired at an average cost of $5.14 per share, for a total transaction of $25,700.00. Following the completion of the transaction, the insider now directly owns 23,037 shares of the company’s stock, valued at $118,410.18. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders bought 11,500 shares of company stock worth $57,615 over the last quarter. Company insiders own 1.20% of the company’s stock.

An institutional investor recently bought a new position in Valeritas Holdings stock. C WorldWide Group Holding A S purchased a new stake in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned about 3.42% of Valeritas Holdings at the end of the most recent quarter. Hedge funds and other institutional investors own 11.65% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at

Several equities research analysts recently issued reports on VLRX shares. ValuEngine cut Valeritas Holdings from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. Wedbush assumed coverage on Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 price objective on the stock. B. Riley reissued a “buy” rating and issued a $10.00 target price on shares of Valeritas Holdings in a research note on Wednesday, May 17th. Finally, Cowen and Company assumed coverage on shares of Valeritas Holdings in a research note on Monday, April 17th. They issued an “outperform” rating on the stock.

Valeritas Holdings Company Profile

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with's FREE daily email newsletter.